Stocktoria
Krystal Biotech, Inc. KRYS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2017-09-20
Chart by TradingView
6/9
Piotroski F — financial health
16.61
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Valuation · market cap as of 2026-06-29
Market cap$11.0B
P / E53.6×
P / S28.2×
P / B9.0×
P / FCF58.1×
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $389.1M | $290.5M | $50.7M | $0 | $0 |
| Operating income | $161.3M | $65.7M | -$109.6M | -$145.2M | -$68.3M |
| Net income | $204.8M | $89.2M | $10.9M | -$140.0M | -$69.6M |
| Operating cash flow | $200.9M | $123.4M | -$88.8M | -$100.6M | -$47.9M |
| Free cash flow | $188.9M | $119.2M | -$100.6M | -$153.5M | -$116.3M |
| Total assets | $1.3B | $1.1B | $818.4M | $558.5M | $626.3M |
| Total liabilities | $114.2M | $109.5M | $39.7M | $36.2M | $32.7M |
| Shareholders' equity | $1.2B | $946.4M | $778.6M | $522.2M | $593.6M |
| Ratios | |||||
| Operating margin | 41.5% | 22.6% | -216.2% | — | — |
| Net margin | 52.6% | 30.7% | 21.6% | — | — |
| FCF margin | 48.5% | 41.0% | -198.4% | — | — |
| Return on assets | 15.4% | 8.4% | 1.3% | -25.1% | -11.1% |
| Return on equity | 16.8% | 9.4% | 1.4% | -26.8% | -11.7% |
| Current ratio | 9.95 | 7.28 | 17.76 | 13.30 | 17.18 |
| Revenue growth | 33.9% | 473.0% | — | — | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Bridgewater Associates, LP | 46,367 | $12.0M |
| RENAISSANCE TECHNOLOGIES LLC | 9,600 | $2.5M |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 16.61 (safe)
- Working capital / assets 0.691
- Retained earnings / assets 0.018
- EBIT / assets 0.121
- Equity / liabilities 10.676
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001711279 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.